Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 10/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | STAT3 | P40763 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Granilin SCHEMBL16596107 | 0.81 | NLRP3 (0.50) | NLRP3CYP2D6CYP2C9CYP2C19STAT3 | |
| SCHEMBL29934916 | 0.78 | PTGS2 (0.50) | NLRP3CYP2D6CYP2C9CYP2C19STAT3 | |
| SCHEMBL29362695 | 0.76 | KMT2A (0.49) | NLRP3CYP2D6CYP2C9CYP2C19STAT3 | |
| Isoalantolactone SCHEMBL8223246 | 0.74 | NLRP3 (1.00) | NLRP3CYP2D6CYP2C9CYP2C19STAT3 | |
| Isoalantolactone SCHEMBL15944432 | 0.74 | NLRP3 (1.00) | NLRP3CYP2D6CYP2C9CYP2C19STAT3 | |
| Isoalantolactone SCHEMBL510111 | 0.74 | NLRP3 (1.00) | NLRP3CYP2D6CYP2C9CYP2C19STAT3 | |
| Isoalantolactone SCHEMBL14029266 | 0.74 | NLRP3 (1.00) | NLRP3CYP2D6CYP2C9CYP2C19STAT3 | |
| Ivalin SCHEMBL27903663 | 0.73 | NLRP3 (0.63) | NLRP3CYP2D6CYP2C9CYP2C19STAT3 | |
| Reynosin SCHEMBL1683362 | 0.70 | PKM (0.51) | NLRP3CYP2D6CYP2C9CYP2C19STAT3 | |
| Reynosin SCHEMBL1683363 | 0.70 | PKM (0.51) | NLRP3CYP2D6CYP2C9CYP2C19STAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4346834-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE | Janssen Pharmaceutica NV (BE) | 2024-04-10 | — | — | EP | disclosed |
| CN-116940351-A | Prodrug compositions and methods of treatment | 阿奎斯蒂弗医疗股份有限公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-116688094-A | Use of p75 extracellular domain in the treatment and/or prevention of rheumatoid arthritis | 苏州澳宗生物科技有限公司 | 2023-09-05 | — | — | CN | disclosed |
| WO-2022254371-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE | JANSSEN PHARMACEUTICA NV (BE) | 2022-12-08 | — | — | WO | disclosed |
| WO-2022235889-A1 | HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF | TVA (ABC), LLC (US) | 2022-11-10 | — | — | WO | disclosed |